SecProbe.io

CORRESP
1
filename1.htm

CORRESP

 Prudential Financial, Inc.

 751 Broad Street

Newark, New Jersey 07102

 July 16, 2025

VIA EDGAR

 U.S.
Securities and Exchange Commission

 Division of Corporation Finance

100 F Street N.E.

 Washington,
D.C. 20549

 Attention: Office of Finance

Re:
 Comment Letter dated June 24, 2025 regarding

 
 Prudential Financial, Inc.

 
 Form 10-K for Fiscal Year Ended December 31, 2024

 
 File No. 001-16707

Ladies and Gentlemen:

 Prudential Financial,
Inc. (the “Company”, “we” or “our”) is in receipt of the comment letter referenced above regarding the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2024 filed with the Securities and Exchange Commission (the “Commission”) on February 13, 2025. We have endeavored to respond fully to your comments. For ease of reference, the headings and paragraphs below
correspond to the headings and comments in the comment letter, with the Staff’s comments presented in bold italicized text, followed by our response to each comment.

Form 10-K for Fiscal Year Ended December 31, 2024

Management’s Discussion and Analysis of Financial Condition and Results of Operations, page 51

1.
 We note your disclosure related to products offered by each segment in your business section starting on
page 3. In order to provide investors with a clear understanding of material trends and the drivers of financial results, please revise MD&A in future filings to:

●

 Provide detail of “Premiums” and “Policy charges and fee income” by product or product
type at the consolidated and/or segment level for each period presented. Also include appropriate discussion of relevant material trends.

●

 Provide detail of “Policyholders’ account balances” by product or product type at the
consolidated and/or segment level at each period end presented.

 Response:

While we acknowledge the Staff’s comment to include additional product and/or product type disclosures in our MD&A,
we note that you suggested additional disclosure in an area that we believe already contains robust disclosure. As a result, we have consulted with our external advisors in connection with your comment. We respectfully note that Item 303 of
Regulation S-K requires that the MD&A address material period-over-period changes in financial statement line items, including through a quantitative and qualitative discussion of the underlying reasons
for those changes. With respect to specific segment and product line information, Item 303 gives broad deference to the registrant, noting that this level of disclosure is required to the extent, “in the registrant’s judgement,” it
“would be necessary to an understanding of such business.” For the reasons outlined below, we believe our existing disclosures are responsive to these requirements.

“Premiums” and “Policy charges and fee income”

We consider the materiality and usefulness of the information we provide to investors and other users of the Company’s
financial statements when preparing our MD&A segment-level disclosures. We believe the current disclosures address the material trends and changes in period over period segment line items required by Item 303, including with respect to revenue,
for both “Premiums” and “Policy charges and fee income,” when and where these revenue sources have a material impact on results or are otherwise necessary to an understanding of the business. We also provide, as required by Item
303, relevant discussion of any material offsetting items to these revenues (e.g., changes in “Premiums” may have a correlating offset in “Policyholders’ benefits”), which provides a more complete understanding of the
performance of the applicable segment. Below is an example from the Results of Operations by Segment MD&A for our International Businesses, beginning on page 84 of our 2024 Form 10-K (emphasis added):

Revenues, Benefits and Expenses

2024 to 2023 Annual Comparison. Revenues from our Life Planner operations decreased $244 million, including a
net unfavorable impact of $295 million from currency fluctuations and a net benefit of $74 million from our annual reviews and update of assumptions and other refinements. Excluding these items, revenues decreased $23 million,
primarily reflecting lower premiums attributable to the decline of business in force in Japan, partially offset by the growth of business in force in Brazil, and lower investment gains from less favorable derivative settlements. These
decreases were partially offset by higher net investment income driven by higher reinvestment rates and higher

 2

policy charges and fee income reflecting growth in both variable and investment products in Japan.

Benefits and expenses from our Life Planner operations decreased $114 million, including a net favorable impact of
$254 million from currency fluctuations and a net charge of $125 million from our annual reviews and update of assumptions and other refinements. Excluding these items, benefits and expenses increased $15 million, primarily reflecting
higher interest credited on policyholders’ account balances, reflecting growth in both variable and investment products in Japan, and higher general and administrative expenses driven by business growth in Brazil. These increases
were partially offset by lower policyholders’ benefits, including changes in reserves, due to the decline of business in force in Japan, as discussed above, as well as favorable changes in estimates of the liability for future policy
benefits.

 As seen above, disclosing “Premiums” in isolation may show a declining trend which a reader might
misconstrue as a sign of lower profitability; however, lower premiums could be a result of reinsurance actions or product mix shifts that would have offsets in “Policyholder’s benefits” or other financial statement line items, and
therefore may result in an immaterial overall impact to segment earnings and profitability. As a result, we believe addressing changes with respect to these select financial statement line items in isolation provides an incomplete picture of our
performance. Further, the current disclosures reflect how management reviews and analyzes the relevant information, allowing investors to “view the registrant from management’s perspective,” one of Item 303’s primary objectives.
For decision-making purposes, product level information is not provided to management at the discrete financial statement line item level, and therefore, management does not review the requested information in isolation as the staff is asking for it
to be disclosed.

 With respect to the Staff’s request regarding “Premiums” in particular, we respectfully
note that we currently include disclosures by product type, where applicable, on Annualized New Business Premiums. We acknowledge the “Premiums” line item on the face of the income statement reflects GAAP revenue recognition
guidance for traditional and limited-payment insurance contracts under ASC 944-605. However, we believe disclosing product-level information on the basis of Annualized New Business Premiums, which
reflects the current level of sales performance for all products of the applicable business, provides a better indication of the Company’s or the applicable segment’s current strategic focus, and helps to better frame current and future
material operating results, including product-related drivers. Specifically, the current disclosure of Annualized New Business Premiums helps the reader quantitatively and qualitatively understand how segment performance has been and can be
impacted by several product-related factors, including, but not limited to: the addition of new products, the discontinuation of existing products, product modifications, changes in the competitive environment and regulatory changes.1 We also note that, beginning with the Company’s first quarter 2025 Form 10-Q, we began disclosing in Note 19. Segment

1
 Our rationale for using Annualized New Business Premiums, along with other segment-specific measures of
performance, is discussed in “Segment Measures” on page 59 in our 2024 Form 10-K.

 3

Information in the Company’s consolidated financial statements expanded income statement-level detail by segment on an adjusted operating income (“AOI”) basis, including
with respect to “Premiums” and “Policy charges and fee income.” While not at the product- or product type-level, we believe this additional detail further enhances the reader’s understanding of segment-level performance for
both revenues and expenses.

 In light of the foregoing, we respectfully note that we do not believe additional MD&A
disclosure regarding “Premiums” or “Policy charges and fee income” at the product- or product type-level would be material or otherwise necessary for “an understanding of [the Company’s] business” as
required and contemplated by Item 303.

 “Policyholders’ account balances”

With respect to the Staff’s request to provide detail of “Policyholders’ account balances” by product or
product type at the consolidated and/or segment level at each period-end presented, we respectfully note that we already disclose additional detail on “Policyholders’ account balances
(“PHAB”)” for segments with significant balances and separate account balances and rollforwards by segment in the notes to the Company’s consolidated financial statements.2 We
also provide detail for the segment measure Account Values for the Retirement Strategies segment and Assets Under Management for the PGIM segment, which we believe are key indicators of these segments’ current and future financial
position and profitability, as they provide a greater understanding of key sources of revenue (e.g., policy charges and fees) that may not directly correspond to GAAP assets on the Consolidated Financial Statements.3 We believe collectively these disclosures provide readers with a similar substantive understanding as compared to the information requested in this portion of the Staff’s comment, making the
latter unnecessary for “an understanding of [the Company’s] business” as required and contemplated by Item 303.

We also respectfully note that we are actively assessing certain aspects of our historical Form
10-K disclosures to determine what enhancements might be made in future filings. One of the sections we have re-evaluated and intend to update is the product information
included in the segment narrative in Item 1. Business. We note that our historical disclosures go beyond addressing the products which are “material to an understanding of the Company’s business taken as a whole” as required by Item
101 of Regulation S-K. We expect to focus this discussion in the 2025 Form 10-K and beyond to highlight the most significant products to better focus readers’
understanding of our business rather than covering the full extent of our product portfolio, as we have historically done. In conjunction with this change, we plan to make corresponding updates to the segment-related disclosures in the MD&A to
ensure congruency.

 As part of our routine disclosure procedures, we will continue to assess and adapt our consolidated
and segment-level MD&A disclosures to provide investors with the information

2
 See Note 13, Policyholders’ Account Balances, beginning on page 239, and Note 8, Separate Accounts,
beginning on page 224, respectively, of our 2024 Form 10-K.

3
 See page 59 in our 2024 Form 10-K for a discussion of these
measures.

 4

we believe will enhance the understanding our financial condition, including, to the extent determined material, specific disclosures at the product and/or product-type level. We represent that
we will consider the suggestions you have made as part of that process.

 Retirement Strategies – Adjusted Operating Income, page
75

2.
 We note your disclosure that adjusted operating income excludes the change in the fair value of the
embedded derivative associated with future projected renewals and only includes the change associated with the current term elected by the policyholder. Please confirm that this adjustment is quantified in the “Change in the value of the non-MRB liabilities, excluding changes in the NPR adjustment” line-item in the table on page 80. If not, please tell us the impact on adjusted operating income in 2024, 2023, and 2022 from this adjustment.
Please tell us and if material, revise future filings to explain why you back this impact out and why the resulting measure is useful for management and investors.

Response:

We acknowledge the Staff’s comment and confirm the adjustment to exclude the change in the fair value of the embedded
derivative associated with future projected renewals from AOI is included in the “Change in the value of the non-MRB liabilities, excluding changes in the NPR adjustment” line item in the referenced
disclosure.

 As disclosed in footnote 4 in the referenced table, this adjustment:

“Represents the change in the liability for our fixed and variable indexed annuities, including the fair value of
embedded derivative instruments associated with those products, which is measured utilizing a valuation methodology required under U.S. GAAP. The total GAAP liability includes the fair value of all index credits for the current term and all future
projected renewals of the policy; however, only changes in the liability associated with the current term elected by the policyholder are included in adjusted operating income, while changes in the liability associated with all future projected
renewals of the policy are excluded from adjusted operating income.”

 The Company’s AOI policy reflects this
distinction between the change in the liability related to index credits for the current term versus the change associated with future projected renewals of the policy. We only purchase hedging derivatives related to the index credits for the
current term of the policy, which is viewed as the economic portion of the liability. Upon policyholder renewal at the end of the current term, the payout from the hedge is expected to cover the interest credited associated with this index term, and
new hedging derivatives – consistent with the policyholder’s elections upon renewal – are purchased to align with the new current term, with this process continually repeating over the life of the policy. Because we can eliminate
certain index strategies or change certain crediting parameters at the end of each index-crediting period, and because policyholders can transfer funds between indexed or fixed strategies upon renewal, we only hedge the current index term for which
there is certain

 5

economic exposure. We, therefore, in turn, consider the liability related to index credits for future projected renewals as non-economic and exclude
changes in the fair value from AOI.

 Notwithstanding the foregoing, in the interests of more fulsome disclosure, we will
expand our existing disclosure within the Retirement Strategies segment discussion in the MD&A by incorporating the following edits in future filings:

Retirement Strategies – Adjusted Operating Income, page 76 (proposed changes in underlined
italics)

 Under U.S. GAAP, policyholder liabilities associated with our fixed and variable indexed annuity
products are recorded in “Policyholders’ account balances,” and include both the contract value that has accrued to the benefit of the policyholder and the fair value of embedded derivative instruments associated with the index-linked
features for these products. The change in the liability for these products is measured utilizing a valuation methodology required under U.S. GAAP and includes the fair value of all index credits for the current term and future projected renewals of
the policy. For the purpose of measuring segment performance, however, adjusted operating income reflects only the change in the liability associated with the current term elected by the policyholder, which is the component of the liability
the C